Form 4: Tenet Healthcare Exec's RSU Vesting & Tax Sales

Tenet Healthcare's EVP, Chief Information Officer, Paola M. Arbour, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Paola M. Arbour, EVP, Chief Information Officer of Tenet Healthcare Corp (THC), reported transactions on February 27, 2026.
• A total of 1,868 restricted stock units (RSUs) granted on February 28, 2024, vested, converting into common stock.
• An additional 2,799 restricted stock units (RSUs) granted on March 1, 2023, also vested, converting into common stock.
• Following vesting, 499 shares were disposed of at $237.58 per share to satisfy withholding taxes.
• Further, 1,838 shares were withheld for tax payment upon vesting of restricted stock units at $239.39 per share.
• An additional 6,810 shares were delivered to satisfy withholding taxes at $239.39 per share.
• After these transactions, Paola M. Arbour beneficially owns 35,791 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While there's a reduction in direct share count due to tax sales, the underlying event is the vesting of equity compensation, which is a positive for the executive and a routine part of compensation plans.

Positives

• The vesting of 1,868 restricted stock units from a 2024 grant and 2,799 restricted stock units from a 2023 grant represents the realization of previously awarded equity compensation for the executive.

Negatives

• A total of 9,147 shares (499 + 1,838 + 6,810) were disposed of or withheld to cover tax obligations, resulting in a reduction of direct common stock ownership.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of past insider transactions.

Industry Context

StockSavvy.ai notes that the vesting of restricted stock units and subsequent sale of shares to cover tax obligations are routine events in executive compensation across various industries. These transactions are a standard mechanism for executives to realize value from their equity awards while fulfilling tax liabilities.

Comparison to Industry Standards

• The practice of executives receiving equity compensation in the form of Restricted Stock Units (RSUs) and then selling a portion of the vested shares to cover tax obligations is a standard industry practice, common among publicly traded companies like Tenet Healthcare.
• This type of transaction is consistent with compensation structures seen in other large healthcare providers and corporations, where equity awards are a significant component of executive pay.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine insider compensation events and not indicative of a change in company fundamentals or executive sentiment towards the company's future.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (RSU vesting and tax-related share sales). It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the event is neutral to the investment thesis.

Keywords

Tenet Healthcare, THC, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Sales, Tax Withholding